Cognis Nutrition and Health, global leader in the manufacture of the most clinically studied brand of CLA (conjugated linoleic acid), recently announced that the U.S. Food and Drug Administration (FDA) issued a ‘no questions letter’ to Cognis’ GRAS notification (GRN 00232). Tonalin® (Tōn-a-lin) CLA has achieved FDA GRAS (generally recognized as safe) status and can be safely used in an expanded range of functional foods and beverages, including dairy products. Cognis offers the food industry one of the most extensive lines of CLA, a naturally sourced, non-stimulant ingredient clinically proven to safely reduce body fat and improve body composition.
For more information about Tonalin® CLA or to place an order, visit www.cognis.com and www.tonalin.com, call 800.673.3702, e-mail cognis.custserv@cognis.com, or fax 513.482.3576.
